Sushrut Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.18 M
as on 08-12-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.50 M
as on 08-12-2024
- Revenue -4.38%
(FY 2022)
- Profit -78.33%
(FY 2022)
- Ebitda -117.65%
(FY 2022)
- Net Worth 1.64%
(FY 2022)
- Total Assets 7.00%
(FY 2022)
About Sushrut Life Sciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jayesh Deshpande, Sakshi Lanjekar, Sameer Rananavare, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233PN2015PTC153693
- Company No.
153693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sushrut Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Deshpande  | Director | 03-Aug-2015 | Current |
| Sakshi Lanjekar | Director | 13-Jan-2015 | Current |
| Sameer Rananavare | Director | 13-Jan-2015 | Current |
| Shailesh Deshpande | Director | 13-Jan-2015 | Current |
Financial Performance of Sushrut Life Sciences.
Sushrut Life Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.38% decrease. The company also saw a substantial fall in profitability, with a 78.33% decrease in profit. The company's net worth moved up by a moderate rise of 1.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sushrut Life Sciences?
In 2017, Sushrut Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kolhapur Jaggery & Foods Private LimitedActive 4 years 4 months
Shailesh Deshpande is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Jun 2016 | ₹0.50 M | Satisfied |
How Many Employees Work at Sushrut Life Sciences?
Unlock and access historical data on people associated with Sushrut Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sushrut Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sushrut Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
